Stereotactic body radiotherapy for localized prostate cancer: Pooled analysis from a multi-institutional consortium of prospective phase II trials
Top Cited Papers
Open Access
- 1 November 2013
- journal article
- research article
- Published by Elsevier BV in Radiotherapy and Oncology
- Vol. 109 (2), 217-221
- https://doi.org/10.1016/j.radonc.2013.08.030
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Prostate alpha/beta revisited – an analysis of clinical results from 14 168 patientsActa Oncologica, 2012
- Hypofractionated Versus Conventionally Fractionated Radiotherapy for Prostate Carcinoma: Final Results of Phase III Randomized TrialInternational Journal of Radiation Oncology*Biology*Physics, 2011
- Phase I Dose-Escalation Study of Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate CancerJournal of Clinical Oncology, 2011
- Acute and Late Toxicity in a Randomized Trial of Conventional Versus Hypofractionated Three-Dimensional Conformal Radiotherapy for Prostate CancerInternational Journal of Radiation Oncology*Biology*Physics, 2011
- The ‘CaP Calculator’: an online decision support tool for clinically localized prostate cancerBJU International, 2010
- Stereotactic body radiotherapy for organ-confined prostate cancerBMC Urology, 2010
- Hypofractionated Intensity-Modulated Radiotherapy for Carcinoma of the Prostate: Analysis of ToxicityInternational Journal of Radiation Oncology*Biology*Physics, 2009
- Virtual HDRSM CyberKnife Treatment for Localized Prostatic Carcinoma: Dosimetry Comparison With HDR Brachytherapy and Preliminary Clinical ObservationsInternational Journal of Radiation Oncology*Biology*Physics, 2008
- Randomized Trial Comparing Two Fractionation Schedules for Patients With Localized Prostate CancerJournal of Clinical Oncology, 2005
- Carcinoma of prostate treated by radical external beam radiotherapy using hypofractionation twenty-two years' experience (1962–1984)Urology, 1990